
Page#1
Table of Contents
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions, except shares in thousands and per share data in dollars)
December 31, December 31, 
 2018  2017
ASSETS 
Current assets: 
Cash and cash equivalents $ 5,342  $ 4,072
Premium and trade receivables 5,150  3,413
Short-term investments 722  531
Other current assets 784  687
Total current assets 11,998  8,703
Long-term investments 6,861  5,312
Restricted deposits 555  135
Property, software and equipment, net 1,706  1,104
Goodwill 7,015  4,749
Intangible assets, net 2,239  1,398
Other long-term assets 527  454
Total assets $ 30,901  $ 21,855
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS AND STOCKHOLDERS’ EQUITY 
Current liabilities: 
Medical claims liability $ 6,831  $ 4,286
Accounts payable and accrued expenses 4,051  4,165
Return of premium payable 666  549
Unearned revenue 385  328
Current portion of long-term debt 38  4
Total current liabilities 11,971  9,332
Long-term debt 6,648  4,695
Other long-term liabilities 1,259  952
Total liabilities 19,878  14,979
Commitments and contingencies 
Redeemable noncontrolling interests 10  12
Stockholders’ equity: 
Preferred stock, $.001 par value; authorized 10,000 shares; no shares issued or outstanding at December 31, 2018 and December 31, 2017 —  —
Common stock, $.001 par value; authorized 800,000 shares; 417,695 issued and 412,478 outstanding at December 31, 2018, and 360,758 issued and 346,874
outstanding at December 31, 2017 —  —
Additional paid-in capital 7,449  4,349
Accumulated other comprehensive loss (56)  (3)
Retained earnings 3,663  2,748
Treasury stock, at cost (5,217 and 13,884 shares, respectively) (139)  (244)
Total Centene stockholders’ equity 10,917  6,850
Noncontrolling interest 96  14
Total stockholders’ equity 11,013  6,864
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 30,901  $ 21,855
The accompanying notes to the consolidated financial statements are an integral part of these statements. 
61
Page#2
Table of Contents
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except per share data in dollars)
 Year Ended December 31,
 2018  2017  2016
Revenues: 
Premium $ 53,629  $ 43,353  $ 35,399
Service 2,806  2,267  2,180
Premium and service revenues 56,435  45,620  37,579
Premium tax and health insurer fee 3,681  2,762  3,028
Total revenues 60,116  48,382  40,607
Expenses: 
Medical costs 46,057  37,851  30,636
Cost of services 2,386  1,847  1,864
Selling, general and administrative expenses 6,043  4,446  3,673
Amortization of acquired intangible assets 211  156  147
Premium tax expense 3,252  2,883  2,563
Health insurer fee expense 709  —  461
Total operating expenses 58,658  47,183  39,344
Earnings from operations 1,458  1,199  1,263
Other income (expense): 
Investment and other income 253  190  114
Interest expense (343)  (255)  (217)
Earnings from operations, before income tax expense 1,368  1,134  1,160
Income tax expense 474  326  599
Net earnings 894  808  561
Loss attributable to noncontrolling interests 6  20  1
Net earnings attributable to Centene Corporation $ 900  $ 828  $ 562
 
Net earnings per common share attributable to Centene Corporation:
Basic earnings per common share $ 2.31  $ 2.40  $ 1.76
Diluted earnings per common share $ 2.26  $ 2.34  $ 1.71
 
The accompanying notes to the consolidated financial statements are an integral part of these statements.
62
Page#3
Table of Contents
CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In millions)
 Year Ended December 31,
 2018  2017  2016
Cash flows from operating activities: 
Net earnings $ 894  $ 808  $ 561
Adjustments to reconcile net earnings to net cash provided by operating activities 
Depreciation and amortization 495  361  278
Stock compensation expense 145  135  148
Debt extinguishment costs —  —  (7)
Deferred income taxes (129)  (108)  92
Changes in assets and liabilities 
Premium and trade receivables (1,173)  (50)  74
Other assets (38)  (146)  167
Medical claims liabilities 1,325  359  145
Unearned revenue (52)  19  43
Accounts payable and accrued expenses (533)  53  402
Other long-term liabilities 258  68  (61)
Other operating activities, net 42  (10)  9
Net cash provided by operating activities 1,234  1,489  1,851
Cash flows from investing activities: 
Capital expenditures (675)  (422)  (306)
Purchases of investments (3,846)  (2,656)  (2,432)
Sales and maturities of investments 1,991  1,862  1,566
Investments in acquisitions, net of cash acquired (2,055)  (50)  (1,297)
Other investing activities, net —  12  —
Net cash used in investing activities (4,585)  (1,254)  (2,469)
Cash flows from financing activities: 
Proceeds from the issuance of common stock 2,779  —  —
Proceeds from borrowings 6,077  1,400  8,946
Payment of long-term debt (4,083)  (1,353)  (6,076)
Common stock repurchases (71)  (65)  (63)
Purchase of noncontrolling interest (74)  (66)  (14)
Debt issuance costs (25)  (3)  (76)
Other financing activities, net 9  5  —
Net cash provided by (used in) financing activities 4,612  (82)  2,717
Effect of exchange rate changes on cash, cash equivalents and restricted cash —  —  (1)
Net increase in cash, cash equivalents and restricted cash 1,261  153  2,098
Cash, cash equivalents, and restricted cash and cash equivalents, beginning of period 4,089  3,936  1,838
Cash, cash equivalents, and restricted cash and cash equivalents, end of period $ 5,350  $ 4,089  $ 3,936
Supplemental disclosures of cash flow information: 
Interest paid $ 323  $ 237  $ 165
Income taxes paid $ 448  $ 496  $ 556
Equity issued in connection with acquisitions $ 507  $ —  $ 3,105
 
The accompanying notes to the consolidated financial statements are an integral part of these statements.
65